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Abstract
Immunoglobulin A deficiency (IgAD) is the most common primary immune deficiency disor-
der in both humans and dogs, characterized by recurrent mucosal tract infections and a pre-
disposition for allergic and other immune mediated diseases. In several dog breeds, low IgA
levels have been observed at a high frequency and with a clinical resemblance to human
IgAD. In this study, we used genome-wide association studies (GWAS) to identify genomic
regions associated with low IgA levels in dogs as a comparative model for human IgAD. We
used a novel percentile groups-approach to establish breed-specific cut-offs and to perform
analyses in a close to continuous manner. GWAS performed in four breeds prone to low IgA
levels (German shepherd, Golden retriever, Labrador retriever and Shar-Pei) identified 35
genomic loci suggestively associated (p <0.0005) to IgA levels. In German shepherd, three
genomic regions (candidate genes include KIRREL3 and SERPINA9) were genome-wide
significantly associated (p <0.0002) with IgA levels. A ~20kb long haplotype on CFA28, sig-
nificantly associated (p = 0.0005) to IgA levels in Shar-Pei, was positioned within the first
intron of the gene SLIT1. Both KIRREL3 and SLIT1 are highly expressed in the central ner-
vous system and in bone marrow and are potentially important during B-cell development.
SERPINA9 expression is restricted to B-cells and peaks at the time-point when B-cells pro-
liferate into antibody-producing plasma cells. The suggestively associated regions were
enriched for genes in Gene Ontology gene sets involving inflammation and early immune
cell development.
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Introduction
Immunoglobulin A (IgA) is the second most abundant antibody in human serum, a key immu-
noglobulin in mucosal defence (secretory IgA) and a trigger of effector functions (serum IgA)
of the immune system [1, 2]. In Caucasians, IgA deficiency (IgAD) is the most common pri-
mary immunodeficiency disorder and affects about 1 in 600 individuals in the general popula-
tion [3]. Many individuals with IgAD are asymptomatic but approximately 1/3 suffer from
recurrent infections at mucosal sites as well as from autoimmune diseases [4–6]. Human IgAD
is a complex disorder presumably influenced by several, yet unknown, genetic alterations. The
α1 and α2 genes, encoding the heavy and the light chains of IgA, are expressed and functional
in IgAD patients. No mutations have been identified within the coding regions of these genes
[7], suggesting a regulatory defect in IgA production or secretion. Similar to many other
immune-mediated diseases, there is a strong correlation between IgAD and genes of the MHC
region [8]. Also non-MHC genes have previously been shown to be associated with human
IgAD including the interferon induced with helicase C domain 1 (IFIH1) and C-type lectin
domain family 10, member A (CLEC16A) genes [9], but no causative mutations have been
identified.
Although a number of murine models for IgAD exist where the phenotype is genetically or
experimentally induced, none of them resemble the human disease [3]. It is recognized that
low concentrations, or even overt deficiency of IgA is present in several dog breeds including
the Shar-Pei [10, 11], selected populations of Beagles [12, 13] and German Shepherds [14]. Just
like humans, dogs with low IgA levels suffer from recurrent infections and immune-related/
mediated health problems [13, 15–17].
Apart from humans, the domestic dog is the species with the largest characterized collection
of naturally occurring genetic diseases, of which more than 350 have been described to clini-
cally resemble the corresponding human disease [18]. Gene mapping in dogs has proven to be
very successful and the list of disease-causing genes that have been identified in dogs is con-
stantly growing (some are reviewed in [19]). Complex diseases are problematic to study even
in dogs. However, a recent study of canine osteosarcoma presented novel approaches by using
genome-wide analyses to unravel pathways and genes involved in this highly polygenic disease
[20].
Although some breeds show low IgA levels, no underlying genetic risk factor has as yet been
described in dogs. A challenge when studying canine IgAD is the lack of an accepted cut-off
value for defining abnormally low serum IgA levels. In a previous study, we performed the larg-
est serum IgA screen in dogs to date (~1300 dogs) representing 22 breeds [15, 17]. In that
study we observed that the IgA ranges varied extensively between the different breeds, which
could partly explain the failure to establish a general canine IgAD cut-off. In the present study,
we used genome-wide SNP data to perform genome-wide association studies (GWAS) in four
breeds prone to low IgA levels according to our previous study [15]; German shepherd (GSD),
Golden retriever (GR), Labrador retriever (LR) and Shar-Pei (SP), aiming to identify new loci
involved in IgAD. In order to handle a phenotype based solely on a continuous and fluctuating
variable with undefined cut-offs in GWAS, we formulated a sliding window-approach using
percentile groups. Following GWAS, we used IgA associated regions from all four breeds and
performed pathway analyses to identify biological pathways and genes of importance for IgAD.
We identified promising candidate genes and pathways to explain IgAD in dogs, involving
early B-cell development, proliferation, class-switching and inflammation.
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Results
IgA levels correlate with age in all breeds and with canine atopic
dermatitis in German shepherd
We first evaluated possible factors acting on IgA levels. We observed no sex-related differences
in IgA levels but a positive correlation with age (S1 Table). The phenotypic variance explained
by age (in dogs older than 1 year) ranged from 4% in German shepherd (GSD) to 25% in Lab-
rador retriever (LR) (Fig 1). In our previous studies [15, 17], we reported significantly lower
IgA levels in GSDs affected by canine atopic dermatitis (CAD) compared to healthy GSDs. In
the present study we used partially overlapping GSD samples and again observed significantly
lower IgA levels in CAD cases compared to controls (Ncases = 101, Ncontrols = 130, p = 8.5 x
10−8). We did not observe any differences in IgA levels between CAD cases and controls in LR
(Ncases = 67, Ncontrols = 74, p = 0.60) or GR (Ncases = 84, Ncontrols = 85, p = 0.72), although these
two breeds are also predisposed to CAD.
Thirty-five GWAS regions nominally associated with IgA levels
We identified three loci significantly associated with IgA levels in GSD and in total 35 regions
nominally associated in the four breeds. GWAS was performed using the 170K Illumina canine
HD array with 496 GSDs (88,704 markers), 129 GRs (100,680 markers), 128 LRs (112,428
markers) and 94 SPs (106,662 markers) passing quality control (Material and Methods and S2
Table) Age was included as a covariate and we controlled for both cryptic relatedness and pop-
ulation sub-structure by using a mixed model approach [21]. In GSD we also took the popula-
tion structure into account by using subpopulation assignment as a covariate (S1 Table). To
remedy potential bias introduced by having no cut-off value and a fluctuating phenotype, we
combined p-values from four different GWAS runs of each breed; three runs were based on
percentile groups of the IgA concentration and analysed as a continuous trait and the fourth
run was a case-control analysis of extreme values (described in detail in Materials and Meth-
ods). Results from each run and quantile-quantile plots are presented in S1–S4 Figs. We set the
nominal significance threshold at p = 0.0005 and SNPs with p-values below this threshold were
considered suggestively associated. In addition, IgA associated regions were defined by linkage
disequilibrium of r2>0.8 within 1 Mb of the suggestively associated SNPs (Fig 1, S5 Fig and
Table 1). The phenotypic variance explained by the top SNPs in the suggestively associated
regions (i.e. one SNP representing each region) ranged from 18% in GSDs to 55% in SP (Fig 1).
SNPs exceeding 97.5% the upper confidence interval (CI), defined empirically using 1,000 per-
mutations, were considered genome-wide significant. Both approaches were consistent with
methods described in Karlsson et al., 2013 [20].
A locus on chromosome 5 associated to IgA levels in German shepherds. In GSD, a ~1
Mb long locus consisting of 14 SNPs on canine chromosome 5 (CFA5) 7,009,995–7,967,689 bp
(CanFam3.1), with p-values ranging from 3.0 x 10−5 to 2.0 x 10−4, passed the threshold of
genome-wide significant association. Based on SNPs in LD (r2>0.8) with the top SNP, we
phased a ~1.7 Mb long region (18 SNPs stretching from 6,392,996–8,122,621), which resulted
in 12 different haplotypes. We defined two risk haplotypes; haplotype 3 and 12 (N = 28 and
N = 95, respectively), one (haplotype 1) as the most common (N = 855) and present in all
groups of dogs independent of IgA levels, and nine rare haplotypes (N3). Heterozygous dogs
carrying haplotypes 1 and 3, and haplotypes 1 and 12 had significantly lower IgA levels com-
pared to dogs homozygous for haplotype 1 (p = 0.04 and p = 0.00008, respectively) (Fig 2).
Despite the large size of the haplotype it harboured only one gene, KIRREL3 (alias NEPH1), a
Genetics of Canine IgA Deficiency
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Fig 1. A combined GWAS in four breeds identifies 35 loci associated with IgA levels. (A-D) The distribution of IgA levels (0–1.40 g/l) clearly varied
between the four breeds, here presented as relative frequency (%) and as box plots with the black box marking percentile 25 to 75 and red bar the median.
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transmembrane protein implicated in development, both in synapse formation and as a regula-
tor of hematopoiesis [22, 23].
In addition to the CFA5 locus, two single SNPs on CFA8 and CFA23 passed the threshold
of genome-wide significance (Fig 1 and S6 Fig). The CFA23 top SNP (CFA23: 48,489,474), not
in LD with any other SNP, was located in the intron of GPR149 (G protein-coupled receptor
149), one of the orphan GPRs with unknown ligands and highly expressed in oocytes (with
important functions for fertility) but also in the brain [24, 25]. The top SNP on CFA8 was in
high LD (r2>0.8) with three SNPs spanning ~0.5 Mb (CFA8: 63,261,755–63,777,575), but
none of the phased 11 haplotypes could be defined as risk or protective (data not shown). This
region contained 13 genes, including GSC (a transcription factor that defines neural-crest cell-
fate specification and contributes to dorsal—ventral patterning [26]), RETNLB (resistin-like
beta, associated with insulin resistance), PPP4R4 (Protein Phosphatase 4, Regulatory Subunit 4,
a putative regulatory subunit of serine/threonine-protein phosphatase 4) and 10 genes in the
SERPINA family (Serpin Peptidase Inhibitor, Clade A (Alpha-1 Antiproteinase), members
1,2,3–6,9–13). SERPINAs are protease inhibitors with multiple immune functions. SERPINA9
has a role in naïve B-cell maintenance and its expression is restricted to the germinal centre of
secondary lymphoid organs where B-cells proliferate [27].
Risk haplotype on chromosome 28 in Shar-Pei. The strongest signal of association to
IgA levels in SP was a region on CFA28 with the top SNP at position 13,512,782 bp. At this
locus, we identified a ~20 kb haplotype (CFA28: 10,496,764–10,517,160) based on 4 SNPs
in high LD (r2>0.8) with p-values ranging from 2.7 x 10−5 to 2.3 x 10−4. In total two rare
(N11) and two common haplotypes were identified. Haplotype 4 was defined as the risk
(N = 108) and haplotype 1 as the protective haplotype (N = 68), as we discovered a significant
difference (p = 0.0005) in IgA levels between dogs homozygous for the risk haplotype (4/4) vs.
dogs homozygous for the control haplotype (1/1). Heterozygous dogs (1/4) had intermediate
IgA levels, significantly different both compared to 1/1 (p = 0.03) and to 4/4 (p = 0.006) (Fig 3)
suggesting an additive nature of the effect. This short haplotype spanned the first intron of the
gene SLIT1, a large extracellular matrix-secreted glycoprotein that functions as a ligand to the
repulsive guidance receptors (Robo) family [28].
Fixation of regulatory sites within SLIT1 in German shepherd. The SP risk allele at
the top SNP (position CFA28: 10,515,232) was completely fixed in both GSD and LR (fre-
quency = 1.0) and had a frequency of 0.90 in other breeds serving as controls (Ndogs = 350)
(S3 Table). We therefore studied this region (expanding it to ~3 Mb; CFA28: 9,000,091–
11,999,424) in more detail by utilizing allele frequencies for 13,004 variants (9486 SNPs and
3518 indels) from an additional 20 GSDs and 20 LRs (S4 and S5 Tables, respectively). We
defined regions of fixation in windows of 11 variants (1 variant overlap) and where the propor-
tion of fixed variants was 1. We identified 79 fixed regions in LR and 356 in GSD within the ~3
Mb region (S6 and S7 Tables, respectively). Next we focused on a closer region around SLIT1,
in total ~400 kb (CFA28: 10,201,240–10,600,160), and identified 169 fixed regions in GSD
forming 14 blocks of fixation out of which four small blocks (130–220 bp) were located down-
stream of SLIT1 and 10 longer blocks (1–9 kb) spanned 134 kb within SLIT1. The block located
furthest upstream of SLIT1 harboured two of the four top IgA associated SNPs in SP, including
the top SNP (CFA28: 10,515,232). Through comparison to human (hg19), we noted a high
The combined GWAS analyses from four runs (IgA levels divided into 2, 3, 4 and 5 groups) are presented in panel E-H, with the nominal significance defined
at-log10p of 3.2 (grey line). In GSD (E), one region (14 SNPs) on CFA5 and single SNPs on CFA8 and CFA23 showed genome wide significance (red line at-
log10p of 3.7) based on 1,000 permutations in five groups. In total, 35 suggestively associated loci (8 in GSD, 8 in GR, 3 in LR and 16 in SP) were defined
based on LD of r2 >0.8 within 0.5 Mb of the top SNP. The fraction of phenotypic variance explained by (I) phenotypic variance explained by age was the
lowest in GSD (4%) and remarkably high in LR (25%) and (J) the top SNP in each of the suggestively associated loci varied from 18% in GSD to 55% in SP.
doi:10.1371/journal.pone.0133844.g001
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Table 1. Genomic loci nominally associated with IgA levels.
SNP Chr Postion pa Alleles Risk
allele
Region start-
end
Size
(kb)
Genes in region Closest gene to
SNP
German shepherd
BICF2P417629 5 7,009,995 3.0E-
05
G/A A 6,498,684–
8,172,621
1,674 KIRREL3, ST3GAL4, DCP KIRREL3 (upstream
of)
BICF2P853011 5 29,238,199 4.6E-
04
T/C C 29,188,112–
29,288,253
100 TMEM123, MMP7 TMEM123 (intron)
TIGRP2P118956 8 63,777,575 8.9E-
05
A/G G 63,211,755–
63,827,575
616 PP4R4, RETNLB, GSC,
SERPINA1,2,3–6,9–13
GSC (upstream of)
BICF2S23435776 10 69,122,184 3.9E-
04
A/C C 69,072,184–
69,174,348
102 ADD2, CLEC4F, FIGLA ADD2 (upstream of)
BICF2G630530840 14 42,224,407 3.8E-
04
A/C A 42,174,407–
42,291,282
117 CHN2 CHN2 (intronic)
BICF2P168717 16 46,117,662 3.0E-
04
A/C A 45,960,356–
46,377,153
417 IRF2, ENPP6 IRF2 (intronic)
BICF2G630365408 23 48,489,474 4.1E-
05
C/A C 48,439,474–
48,539,474
100 DHX36, GPR149 GPR149 (intronic)
BICF2P247941 27 37,404,652 4.6E-
04
T/C T 37,248,047–
37,454,652
207 SLC2A4,14, NANOG, FOXJ2,
C3AR1
FOXJ2 (upstream of)
Golden retriever
BICF2P856602 6 18,062,312 1.6E-
04
C/T T 18,011,946–
18,112,312
100 Many! PPP2CB (intronic)
BICF2P442233 21 45,973,013 4.4E-
04
T/C T 45,923,013–
46,023,013
100 LUZP2 LUZP2 (intronic)
BICF2P261279 26 7,164,610 3.9E-
05
G/A A 7,114,611–
7,846,707
732 Many! Lrrc43 (intronic)
BICF2G630261705 28 37,236,337 2.5E-
04
T/C T 37,228,122–
37,362,478
134 none MKI67 (upstream of)
BICF2S232271 29 11,752,985 3.2E-
04
A/G G 10,808,328–
11,803,162
995 LINC01301, CLVS1, YWHAZ,
RAB2A, CHD6, CHD7, CLVS1
CLVS1 (intronic)
BICF2P877790 34 10,311,397 4.4E-
04
C/T T 10,261,397–
10,685,205
424 IRX2, C5orf38 IRX2 (downstream
of)
BICF2P963046 34 21,820,555 4.7E-
05
G/T G 21,406,221–
22,589,723
1183 TPRG1, TP63, LEPREL1,
CLDN1, THEM207, IL1RAD,
CLDN16
TP63 (upstream of)
BICF2P1301719 34 41,393,801 4.4E-
04
C/T C 41,343,801–
41,751,420
408 LRMP LRMP (upstream of)
Labrador retriever
BICF2G630378390 23 24,721,148 3.8E-
04
G/A G 24,665,511–
24,771,148
106 SATB1, LOC339862 SATB1 (downstream
of)
TIGRP2P306755 23 42,076,158 3.3E-
04
C/T C 42,026,107–
42,142,835
117 None PLSCR5 (upstream)
BICF2P227171 30 17,867,239 4.9E-
04
T/C T 17,817,239–
17,917,239
100 GNB5, MYO5C GNB5 (intronic)
Shar-Pei
BICF2S23136666 4 31,168,913 3.2E-
04
C/A A 31,118,913–
31,218,913
100 NRG3 NRG3 (intronic)
BICF2G630552985 7 15,555,664 4.1E-
04
G/A A 15505664–
15,605,664
100 None ZNF648 (upstream
of)
BICF2S23410286 7 16,196,250 2.4E-
04
C/T T 16,146,250–
16,246,197
100 NPL, DHX9 NPL (intronic)
BICF2P1401994 7 17,786,665 1.3E-
04
C/T T 17,736,665–
17,836,665
100 C1orf21 C1orf21 (intronic)
(Continued)
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regulatory potential within the 134 kb region. Specifically, there were predicted binding sites
for the transcription factor CTCF within four fixed blocks in GSD including the block with the
SP top SNPs (Fig 3 and S7 Fig). In LR, we identified 37 fixed regions (within the ~400 kb)
forming four blocks (ranging from 130 to 242 bp in size) but none were located within or near
SLIT1.
Domestication sweep within SLIT1. To test whether the increased degree of fixation in
this region may be associated with selection during initial dog domestication, we analysed our
previously published pooled whole-genome resequencing data representing 12 wolves and 60
dogs from 14 diverse breeds [29]. We noted a distinct increase in Fixation Index FST (FST =
0.68 and 0.67; Z(FST)>4) and a decrease in dog heterozygosity HP (HP = 0.12 and 0.14; Z(HP)
<-2.6) in two consecutive windows (spanning CFA28: 10,403,080–10,478,044) within the
SLIT1 gene, 37 kb downstream from the top associated SNP and 19 kb from the end of the
associated haplotype in SP (Fig 3, S7 Fig and S8 and S9 Tables).
Pathway analyses
Genes involved in inflammation dominate pathways of IgA associated regions. While
the different breeds had no overlapping association signal, we wanted to explore if common
pathways could be found among the different risk loci. We identified significant connectivity
between genes in the IgA associated regions across three breeds (GSD, GR and SP but not LR)
Table 1. (Continued)
SNP Chr Postion pa Alleles Risk
allele
Region start-
end
Size
(kb)
Genes in region Closest gene to
SNP
BICF2S23136652 7 19,673,829 7.1E-
05
T/C C 19,623,829–
19,723,829
100 MTFR1, PTGS2 PTGS2 (intronic)
BICF2P1436700 7 22,764,328 4.4E-
04
A/G G 22,714,328–
22,814,328
100 ASTN1, PAPPA2 ASTN1 & PAPPA2
(downstream of)
BICF2P215640 8 16,058,011 2.0E-
04
A/G G 16,008,011–
16,108,075
100 MIPOL1, FOXA1 MIPOL1 & FOXA1
(downstream of)
BICF2S2361733 22 20,899,197 4.1E-
04
T/G G 20,848,859–
20,949,206
100 none none, closest gene
is PCDH9
TIGRP2P320304 24 41,301,998 3.3E-
04
T/C C 41,251,998–
41,351,998
100 CBLN4 downstream of
CBLN4
BICF2S23711428 28 5,983,856 1.2E-
04
G/T T 5,933,856–
6,033,856
100 HECTD2 HECTD2 (upstream
of)
BICF2G630276743 28 7,733,212 2.4E-
04
T/C T 7,683,212–
7,803,352
120 MYOF, CEP55, FFAR4 MYOF (intronic)
BICF2G630276012 28 9,909,408 1.2E-
04
A/G G 9,859,408–
9,994,305
135 TLL2, TM9SF3, PIK3AP1 TM9SF3 (intronic)
BICF2G630275788 28 10,515,232 2.7E-
05
G/A G 10,446,800–
13,077,479
2,631 Many! SLIT1 (intronic)
BICF2P677609 28 18,823,291 2.2E-
04
A/G G 18,773,291–
18,873,291
100 SORCS1 SORCS1 (intronic)
TIGRP2P404896 35 1,981,709 2.9E-
04
C/T T 1,931,709–
2,031,709
100 FOXC1 FOXC1 (intronic)
BICF2G630772654 35 8,300,115 2.7E-
04
G/A A 8,250,009–
8,350,115
100 SLC35B3 SLC35B3
(downstream of)
A total of 35 IgA associated regions were deﬁned across four dog breeds based on SNPs in strong linkage disequilibrium (LD, r2 >0.8) and within 1 Mb of
the top SNP (plus the ﬂanking 50 kb). All regions except four, contained one or more protein-coding genes. Displayed in the table are the genomic
positions (Canfam 3.1) of the associated regions, information about the SNPs including p values (a P1df) and gene content.
doi:10.1371/journal.pone.0133844.t001
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using the PubMed-based program GRAIL [30]. The genes were connected by pathway key
terms (S10 Table). We aimed at defining common pathways across many of our regions and
found that the pathways representing numerous (7 or 8) regions were ‘serum’ (rank #7), ‘insu-
lin’ (#8), ‘matrix’ (#10), ‘carcinoma’ (#13) and ‘complement’ (#16) (Table 2). Four out of nine
genes with significant GRAIL p-value were clearly involved in inflammation such as two SER-
PINA genes (SERPINA9 and SERPINA12, inhibits proteases), C3AR1 (Complement Compo-
nent 3a Receptor, a major player in the complement system) and IL31 (Interleukin-31, a T-cell
derived cytokine associated with chronic skin inflammation and pruritus). Additional genes
Fig 2. Two risk haplotypes at the German shepherd CFA5 locus results in lower IgA levels. (A) The genome wide significant locus on CFA5 consisted
of 17 SNPs (grey circles) in LD (r2 >0.8) with the top SNP (white), with only the KIRREL3 gene within the associated region and six genes adjacent. (B) The
18 SNPs were phased into 12 different haplotypes, of which nine were rare (N <3). Haplotype 1 was the most common (N = 855) and the remaining two
haplotypes; 12 and 3 were more similar to each other than to haplotype 1. (C) Dogs homozygous for haplotype 1 (1/1) represented all groups of IgA evenly,
whereas dogs heterozygous 1/12 and 1/3 had significantly lower IgA levels compared to 1/1 (p = 0.04 and 0.0008, respectively).
doi:10.1371/journal.pone.0133844.g002
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Fig 3. The SLIT1 gene harbours an associated haplotype in Shar-Pei and fixed blocks in German shepherd. (A) In SP, four SNPs (grey circles)
suggestively associated to IgA levels, were located within the first intron of SLIT1. (B) A distinct increase in the degree of genetic differentiation (FST) between
Genetics of Canine IgA Deficiency
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with GRAIL p<0.05 were GRP149 and four different enzymes: PTGS2 (prostaglandin-endo-
peroxide synthase 2, the key enzyme in prostaglandin biosynthesis),HOGA1 (4-hydroxy-
2-oxoglutarate aldolase 1, a mitochondrial enzyme), ALDOA (aldolase A, a glycolytic enzyme)
and NPL (N-acetylneuraminate pyruvate lyase, an enzyme which catalyzes sialic acid) (Table 2
and S10 Table).
Gene sets enriched in IgA associated regions. We also used INRICH to search for gene
set enrichment based on the Gene Ontology (GO) database [31]. In total 51 gene sets were sig-
nificantly (p0.05) enriched in our regions and the top nine also reached significance after
correction for multiple testing (pcorrected0.05) (S11 and S12 Tables). There were 11 gene
sets (four with pcorrected0.05) relating directly to transcriptional activity, including the top
term (GO:0003700, p = 3.0 x 10−6). The other top gene set was response to estradiol stimulus
(GO:0032355, p = 3.0 x 10−6). We also hit gene sets related to haematopoiesis (GO:0030097,
p = 8.0 x 10−4) and platelets (GO:0031093 with pcorrected = 0.03, GO:0002576, GO:0030168 and
GO:0007596; p ranging from 8.5 x 10−5 to 1.1 x 10−3). We detected gene sets related to cytokine
responses (GO:0034097, p = 1.5 x 10−4, pcorrected = 0.05) and lipopolysaccharide (GO:0032496,
p = 6.0 x 10−4). The additional gene sets significant after correction were regulation of cell
growth (GO:0001558, p = 1.0 x 10−5) and actin filament organization (GO:0007015, p = 8.3 x
10−5).
Discussion
Despite the attention IgA levels in dogs have received in the past, the normal range of serum
IgA as well as a generally accepted cut-off value for IgAD has not yet been established. In a pre-
vious study [15], we found that the IgA levels vary extensively between breeds, which could
explain the lack of an accepted cut-off. The literature often reports breed-specific IgA values
and suggested cut-offs for canine IgADmark the lower limit for the 95% confidence interval
for the mean in the studied populations [11, 13, 32]. However, this does not mark a physiologi-
cally proven threshold to distinguish between low levels of IgA and IgAD in dogs.
Combining association p-values distinguish true signals
In this study we did not set out to define a cut-off that determines IgAD. Instead, we used four
breeds, identified from our earlier study as breeds with generally low serum IgA levels, in
GWAS to identify genes and pathways that could be of relevance for both canine and human
IgAD. We also suggest a novel approach to perform genome-wide association mapping of
complex continuous traits using multiple runs of groups based on percentile intervals instead
of the actual value. The rationale behind this approach originates from several factors compli-
cating the interpretation. First, the lack of a generally accepted cut-off value to distinguish nor-
mal IgA levels from deficient in dogs hinders an appropriate case-control association study.
Second, IgA levels are known to fluctuate depending on the environmental exposure at the
time-point of sampling. Third, the IgA ranges (as well as mean and median values) vary widely
between breeds and [15] therefore an approach that takes breed differences into account is
dogs and wolves span a 75 kb region (windows with FST >0.67 are coloured in black) within the SLIT1 locus, with FST values of two consecutive 50 kb
windows reaching 0.68 and 0.67, respectively (windows with FST >0.43 are coloured in grey). More extreme genetic differentiation was only seen in 7% of the
whole dog genome, potentially indicating that IgA levels may have been affected in a pleiotropic manner by primary selection affecting another primary target
(such as brain function) during dog domestication. Blocks of fixation were identified in GSD, spanning several regulatory sites including binding sites for the
transcription factor CTCF. (C) The top SNPs in SP were in high LD (r2 >0.8) and phased into four haplotypes where two were common (1 and 4) and two were
rare (2 and 3). Dogs homozygous for 1/1 had significantly higher IgA levels compared to dogs homozygous for 4 (4/4) and heterozygous 4/1 (p = 0.0005 and
p = 0.03, respectively). Additionally, homozygous 4/4 had significantly lower IgA levels than heterozygous 4/1 (p = 0.006) indicating an additive effect of the
risk and/or protective haplotype.
doi:10.1371/journal.pone.0133844.g003
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proposed. The rationale behind combining p-values from three different percentile series is to
remove the strict cut-offs created between percentile groups. In this way we also dilute false
positives and increase the chance to distinguish the true signals. To the three series of percentile
groups, we also added a robust case and control analysis with the necessary removal of dogs
with intermediate IgA levels (cases<25% percentile, controls>75% percentile) in order to
cover the possibility that extreme values would detect signals. Thus, the statistical model we
Table 2. GRAIL pathways of the IgA associated regions.
Chr Region start-end Genes GRAIL p
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German shepherd
8 63,211,755–63,827,575 SERPINA1 0.13 • • • •
8 63,211,755–63,827,575 SERPINA3 0.064 • • • •
8 63,211,755–63,827,575 SERPINA4 0.17 • •
8 63,211,755–63,827,575 SERPINA6 0.19 • •
8 63,211,755–63,827,575 SERPINA9* 0.037 •
8 63,211,755–63,827,575 SERPINA12* 0.019 •
10 69,072,184–69,174,348 FIGLA 0.12 • • • •
23 48,439,474–48,539,474 GPR149 0.0018 •
27 37,248,047–37,454,652 C3AR1* 0.014 • • •
27 37,248,047–37,454,652 SLC2A3 0.16 • •
5 29,188,112–29,288,253 MMP7 0.18 • • •
Golden retriever
6 18,011,946–18,112,312 ALDOA 0.048 •
6 18,011,946–18,112,312 TBX6 0.12 •
26 7,114,611–7,846,707 DIABLO 0.15 •
26 7,114,611–7,846,707 IL31* 0.0056 • • •
Shar-Pei
28 10,446,800–13,077,479 MORN4 / C10orf83 0.075 •
28 10,446,800–13,077,479 HOGA1 /C10orf65/NPL2 0.013 •
28 10,446,800–13,077,479 CHUK 0.16 • •
28 10,446,800–13,077,479 CPN1 0.10 • •
28 10,446,800–13,077,479 HPSE2 0.11 • •
28 10,446,800–13,077,479 NKX2-3 0.10 • • •
28 10,446,800–13,077,479 SFRP5 0.17 •
7 19,623,829–19,723,829 PTGS2 0.049 • • •
7 22,714,328–22,814,328 ASTN1 0.14 •
7 22,714,328–22,814,328 PAPPA2 0.071 • • • • •
7 16,146,250–16,246,197 DHX9 0.17 •
Total number of genes 14 9 10 12 10
Total number of regions 8 7 7 7 7
Genes in the 35 IgA associated regions across four breeds were analysed for their connectivity using the web-based software GRAIL. This table display
the ﬁve pathways represented by multiple regions (7 or 8) and breeds (GSD, GR and SP). Out of the eight genes (bold) that were assigned a signiﬁcant
GRAIL p (<0.05) based on the connectivity to genes in other IgA associated regions, half were involved in inﬂammation (marked with an asterisk*).
doi:10.1371/journal.pone.0133844.t002
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used for identifying loci associated with IgAD are based on a continuous analysis but developed
to fit the actual phenotype. In humans, IgA levels are normally higher in males [33, 34] whereas
in dogs the reports are conflicting [12, 35, 36]. In our large set of samples we could not detect
any difference in IgA levels between the sexes.
IgA associated regions. We identified 35 loci nominally associated with IgA levels in the
four different dog breeds. Interestingly, none resided within the MHC gene region. In GSD
we identified genome-wide significantly associated SNPs possibly due to GSDs having strong
risk factors or simply because the sample set (~500) was large enough to reach significance.
Although the number of SPs was much lower (~100), we detected one haplotype (within
SLIT1) significantly associated to IgA levels that is likely to contribute to the large proportion
of the phenotypic variance explained (55% by top SNPs). The smaller sample sets in combina-
tion with many risk factors with small effects are likely the reason for the lack of significant
results in the other breeds. GSD and SP are breeds that have been repeatedly identified as
‘high-risk IgAD breeds’ by us and by others [10, 11, 14, 15, 36–38]. Our genetic results are in
concordance with these previous reports, as GSD and SP appear to carry the strongest risk fac-
tors for low IgA levels.
Candidate genes implicated in early B-cell development
Human IgAD is not associated with an absence or decrease in the B-cells themselves, but a fail-
ure of B-cells to differentiate into mature IgA-secreting plasma cells [39]. In dogs, less is
known about the disease mechanism but clinically it appears similar to human IgAD. The
development of B-cells begins in the bone marrow with the formation of blood compartments
from hematopoietic stem cells (hematopoiesis). With regards to B-cells it also includes the
genetic recombination of heavy and variable chains (referred to as V(D)J-joining). Interest-
ingly, IgAD in humans also seem to involve stem cells as the phenotype can be transferred by
bone marrow transplantation [40]. In our study we identified two significantly associated
regions harbouring the novel candidate genes KIRREL3 and SLIT1 with documented roles in
hematopoiesis.
KIRREL3 was the only gene within the long-range (~1.7 Mb) haplotype on CFA5, signifi-
cantly associated with IgA levels in the GSDs. This transmembrane protein is widely expressed
in the nervous system [41] where it has been implicated in synapse formation and abnormal
brain function [22, 42] and hence is an important developmental gene. Moreover, a homolog
of KIRREL3 (mKirre) has been reported as one of the genes needed to support and regulate
hematopoiesis in bone marrow, which suggest that its developmental function also covers the
formation of lymphocytes (including B- cells)[23].
The significantly associated haplotype in SP was located in the first intron of the SLIT1
gene. The haplotype analysis revealed an additive effect where dogs homozygous for either the
risk or protective haplotype were significantly different from the heterozygous dogs, which
strengthens the possibility that it is functional. The SLIT proteins and their Robo receptors
form complexes with conserved guidance cues for repulsion, attraction or branching that influ-
ences cell migration and proliferation of cells in the central neural system as well as immune
cells [28, 43–45]. Robo/SLIT has been demonstrated to modulate the chemo attractant-induced
migration of mature leukocytes through inflammation as well as axon migration and branching
during development [46, 47]. A similar cue mechanism of Robo/SLIT appears to regulate hom-
ing, self-renewal, migration and proliferation of hematopoietic stem and progenitor cells in the
bone marrow [48–50]. In addition, missense mutations in SLIT1 have been connected to aplas-
tic anemia (AA), a rare but life-threatening bone marrow failure syndrome [51], which also
support the role of SLIT1 in early hematopoiesis.
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Signals of selection in SLIT1 indicate pleiotropic effects. We found that GSDs were
fixed for regions within SLIT1 with high regulatory potential and binding sites dominated by
the transcription factor CTCF, a highly conserved zinc finger protein with various genomic
regulatory functions including transcriptional activation/repression and with a critical role in
coordinating DNAmethylation and higher-order chromatin loops [52]. Moreover, CTCF has
a known role in V(D)J recombination in B and T cells [53]. When comparing wolves to dogs
and evaluating the FST, we identified a 75 kb domestication sweep signal, based on two conse-
cutive windows with FST = 0.68 and 0.67. This degree of fixation deviates from the average FST
between dog and wolf (mean FST = 0.33) by more than 4 standard deviations and a similar or
more extreme differentiation is only observed in 7% of the dog autosomal genome, indicating
that selection at SLIT1may have contributed to important dog domestication features, which
typically affect brain function [29].
We find it interesting that one of our candidate genes are restricted to B-cells (SERPINA9)
and the other two (KIRREL3 and SLIT1) share the features of being essential in both brain and
immune cell development. Both KIRREL3 and SLIT1 are recognized for their function in the
nervous system, and only recently it has become evident that Robo/SLIT signalling as well as
KIRREL3 are also key players in immune cell development. Moreover, KIRREL3 knock-out
mice display a loss of male-male aggression [54] implicating changes in behavior connected to
this gene. As dog selection often target behavioural traits we speculate that a selective pressure
on these two genes could also have enriched for immune defects in a pleiotropic manner.
Altogether, the two genes (KIRREL3 and SLIT1) suggest an alteration in early B-cell devel-
opment in canine IgAD. As the generation of circulating B-cells, their migration and prolifera-
tion pattern are not known in dogs, defects at the hematopoietic level cannot be excluded.
Interestingly, hematopoiesis was also highlighted in our gene set enrichment analysis. Further-
more, early B-cell development defects characterize a variety of immunodeficiency disorders in
humans [55].
Genes potentially involved in B-cell proliferation
Class-switch recombination (CSR), is a process involved in the late proliferation steps before
B-cells differentiate into plasma cells and occurs in the germinal centres of secondary lymphoid
organs. Similar to V(D)J joining in early B-cell development, class-switching also involves
DNA recombination, and represents the process in which the immune system produces anti-
bodies of different isotypes. Two important signals to initiate germinal centre reactions, such
as CSR, is the engagement of the B-cell receptor complex (by antigen) or CD40 (by CD40L).
An interesting gene for CSR is SERPINA9, located within the genome-wide significant associa-
tion signal (GSD CFA8) and with a significant GRAIL p-value. The expression of SERPINA9 is
restricted to B-cells in germinal centres of secondary lymphoid organs where it inhibits tryp-
sin-like proteases. Interestingly, the expression of SERPINA9 is enhanced in vitro by CD40/
CD40L signaling and down regulated once these cells are differentiating into circulating
plasma- or memory cells [27]. Thus, this gene is not only highly interesting for IgAD due to its
restricted expression pattern, but also as it appears to play an important role in the complex
array of events leading to specific antibody responses.
Pathways implicate genes involved in inflammation
It is not known whether IgAD actually originates from B-cells themselves, or if the phenotype
reflects impairments in T-helper cells, of antigen-presenting cells (which both stimulate the
differentiation and proliferation of B-cells), or even abnormalities in the cytokine network
[6]. Both programs used for the pathway analyses detected pathways related to the immune
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system; GRAIL specifying genes predominantly in inflammation (SERPINA9/12, C3AR1, and
IL31) and INRICH gene sets involving early development of immune cells, cytokine responses
and platelet activation.
A potential bias towards inflammation. The majority of the sample set for this study was
initially collected as cases and controls of other immune-related disease phenotypes such as
CAD (GSD, GR, LR), pancreatic acinar atrophy (GSD) and Shar-Pei autoinflammatory disease
(SP). Consequently, the breeds in the study are predisposed for these disease phenotypes (in
addition to low IgA levels) and the dogs sampled were specifically selected, the incidence of dis-
ease within the sample cohort is probably not representative for the whole breed. If we also
consider the poorly understood connection between IgAD levels and autoimmunity, asthma
and allergy [6], genetic risk factors of immune-mediated diseases (predominantly inflamma-
tory diseases in our cohort) may theoretically affect the low IgA dogs in our sample set and
introduce a bias leading to the association to genomic regions involved in the various immune
diseases and not primarily to low IgA levels. However, in our previous paper [15] where we
performed serum IgA screening in ~1300 dogs (22 breeds), we also performed correlation anal-
yses between IgA levels and some breed’s specific immune disease. The breeds and diseases
studied included GSD (CAD and pancreatic acinar atrophy), LR (CAD), GR (CAD), SP (Shar-
Pei autoinflammatory disease), Standard poodle (Addison’s disease), Bearded collie (Addison’s
disease), Nova Scotia duck tolling retriever (steroid responsive meningitis arteritis), Jämthund
(diabetes mellitus) and Giant Schnauzer (lymphocytic thyroiditis). Remarkably, IgA levels did
only show correlation to CAD (p<0.0001) and pancreatic acinar atrophy (p = 0.04) and to no
other diseases in any other breed.
Low IgA levels correlated to CAD in German shepherd. Possibly, there is an IgA depen-
dent CAD and an IgA independent CAD since CAD clearly correlates to low IgA levels in GSD
but not in GR and LR. In our previous study [17] we detected a genome-wide significant signal
associated with CAD in GSDs when the effect of IgA levels was taken into account. Without
the IgA levels the signal was absent suggesting that the CAD phenotype in GSD is partly caused
by low IgA levels rather than the opposite scenario; that CAD would cause low IgA levels in the
dogs as a secondary effect. In this present study, several genes, with possible functions in CAD,
were significant in the GRAIL pathway analyses; C3AR1 has been associated with childhood
bronchial asthma, a common chronic inflammatory disease characterized by hyperresponsive
airways, excess mucus production, eosinophil activation, and the production of IgE [56]; IL31
involved in skin inflammation and pruritus [57] and in inflammatory bowel disease; and the
SERPINA gene family with its anti-inflammatory properties are interesting for inflammatory
disease. Hence, the genes influencing IgA levels could possibly predispose to CAD directly, or
indirectly through the effect of having low IgA levels.
Conclusion
IgAD is a complex disease phenotype influenced by multiple unknown genetic factors. In this
comparative study, we took advantage of the beneficial genome structure in dog breeds, its
resemblance to the human disease phenotype and used a new approach to handle a continuous
variable. This resulted in the successful mapping of four genomic regions significantly associ-
ated to IgA levels in dogs with suggested disease mechanisms involving early B-cell develop-
ment (candidate genes KIRREL3 and SLIT1) and proliferation of B-cells (candidate gene
SERPINA9). In addition, pathway analyses of 35 nominally associated regions also implicated
inflammatory routes, which suggest an aetiology of IgAD to not be restricted to the humoral
immune response but also to the innate immune system and inflammatory responses.
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Materials and Methods
Samples
Blood samples, EDTA blood for DNA extraction and serum for IgA quantification, were col-
lected from 1101 privately owned, purebred dogs including 516 German shepherds (GSD), 187
Golden retrievers (GR), 302 Labrador retrievers (LR) and 96 Shar-Pei (SP) in collaboration
with veterinarians in the United States, Sweden and Switzerland. Owner consent was collected
for each dog. Ethical approvals were granted by the Swedish Animal Ethical Committee C139/
9 and C2/12 (the Swedish animal Welfare Agency no. 31-4714/09 and 31-998/12, respectively).
The Broad Institute: Lindblad-Toh 0910-074-13 and the canton of Bern: Tosso Leeb 23/10.
Serum was separated from the red blood cells by centrifugation and stored at -20°C until used.
Genomic DNA was extracted from EDTA blood samples using the Qiagen midi prep extrac-
tion kit (Qiagen, Hilden, Germany), diluted in de-ionized water and stored at -20°C until used.
Quantification of Immunoglobulins using Canine IgA ELISA
Serum IgA levels were quantified by using a capture enzyme-linked immunosorbent assay
(ELISA) protocol described previously [15, 17, 58] and all samples were quantified as part of
previous study [15]; except for 191 GSDs already quantified as part of our previous CAD
GWAS [15, 17, 58] and for the addition of serum samples from 197 GSDs for the current
study. All samples were quantified at least four times. Samples showing strong variation
between duplicates were run up to six times and potential outliers were subsequently excluded.
Two samples (both LR) were also excluded for being potential outliers due to very high IgA
concentration (1.98 g/l and 1.88 g/l). In short, serum samples were measured for their serum
IgA concentration using polyclonal affinity purified goat anti-dog IgA antibodies (AbD Sero-
tec, Oxford, UK) and alkaline phosphatase-conjugated polyclonal goat anti-dog IgA (Bethyl
Laboratories, TX, USA). The antibodies were diluted 1:2,000 with carbonate-bicarbonate buffer
(0.05 M, pH 9.6) respectively, Tris-buffered saline and Tween (TBST). Samples were diluted
1:25,000; 1:50,000 and 1:100,000 with phosphate-buffered saline with Tween (PBST). Para-
Nitrophenylphosphate (PNPP) was used as substrate. Serum samples from dogs, kindly pro-
vided by Professor M.J. Day (Bristol University, England) with previously determined IgA con-
centrations were used as controls for each individual measurement. The quantification of
serum IgA in the sample set has been described in our previous study [15] and the distribution
is presented for the current data set in Fig 1 and S13 Table.
SNP genotyping and quality control
The initial data set for GWAS consisted of 1101 dogs genotyped by the 170K Canine HD Bead-
Chip (Illumina San Diego, CA, USA) as part of various other dog projects within our research
group. The four breeds were analysed separately. An iterative quality control was performed of
the 170K markers prior to further analyses in order to remove non-informative markers (SNPs
with a minor allele frequency below 5%) and poorly genotyped markers (call rate0.95). Dogs
were excluded due to trait or covariate missing and with an age below one year, too high iden-
tity by state (IBS0.95), low call rate (0.95) or if showing too high autosomal heterozygosity
(95%). The breakdown of the dataset and the quality control are shown in S2 Table and the
final dataset used in GWAS consisted of 496 GSDs (88704 markers), 129 GRs (100680 mark-
ers), 128 LRs (112428 markers) and 94 SPs (106662 markers). All coordinates presented in the
results are from the CanFam3.1 genome assembly (Sept. 2011).
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Correlation to fixed effects
We used Pearson's product moment correlation coefficient to test if the variables age, sex, sub-
populations (if present) and canine atopic dermatitis (CAD, in GSD, GR and LR) were corre-
lated with IgA levels.
Genome-wide association studies
We tested for association between IgA levels and genetic markers in all four breeds separately
and used the age in years at sampling as a covariate. When analysing GSDs, we also included
subpopulation assignment as a covariate. Cryptic relatedness and population sub-structure
were controlled through a mixed model approach [21] and the GenABEL package ver. 1.7–0
[59], part of the R statistical software ver.2.14.2 [60], was used.
Four different GWAS runs were performed in each breed separately. The IgA levels were
divided into groups of percentile intervals; the 20% percentile creating five groups (0–20, 21–
40, 41–60, 61–80, 81–90), the 25% percentile creating four groups (0–25, 26–50, 51–75, 76–
100) and the 33,3% percentile creating three groups (0–33, 34–67, 68–100). The percentile
groups formed in each breed as well as the number of dogs within each group are presented in
S14 Table. The analyses were performed using the group number as its phenotype label (in a
close to continuous analysis manner). The fourth GWAS was formed with cases and controls;
dogs with IgA levels lower than the 25% percentile as cases and levels higher than the 75% per-
centile as controls, thus the middle group was excluded resulting in a lower number of dogs
compared to the other GWAS datasets. The p-values from these four runs were then combined
(for each breed separately) using the following formula:
p^ ¼
Yn
i¼1
pi
 !1
n=
, where p^ is a vector of merged p-values, p_i is a vector of i-th run of association study and n is
the number of runs. We then used p^ values for deﬁning associated SNPs at the ﬁnal stage of the
analyses.
Threshold for associated SNPs and regions
Similarly to Karlsson et al. [20], we defined genome-wide significance using 95% CIs calculated
from the empirical distribution of p-values observed by rerunning the GWAS with randomly
permuted phenotypes 1,000 times. For each breed separately, SNPs exceeding the 97.5% upper
empirical CI were defined as genome-wide significant in that breed. The permutations were
performed in each percentile group independently (i.e. four separate runs per breed, S8 and S9
Figs) and if more than one run resulted in SNPs crossing the 97.5% upper CI the strictest
threshold was used to define the genome-wide significant SNPs in the combined analysis.
SNPs were considered suggestively associated if p<0.0005, using the uncorrected p-value
(P1df). We used uncorrected p-values (no genomic control), since the mixed model framework
already sufficiently corrected for population structure. IgA associated regions were based on
the latter threshold and defined using strong linkage disequilibrium (LD) of r2>0.8 within
1 Mb of top SNP (according to methods described in Karlsson et al. [20]).
Variance explained by top loci and fixed effects
We calculated the phenotypic variance explained by fixed effects (age) and by the top SNPs in
the IgA associated regions. We used five percentile groups as the phenotype and calculated
Genetics of Canine IgA Deficiency
PLOS ONE | DOI:10.1371/journal.pone.0133844 July 30, 2015 16 / 24
variance explained by comparing the original phenotypic variance with the residual variance of
a linear mixed model with appropriate fixed effects included (age in our case). We used stan-
dard jackknife resampling to determine the variance estimation error.
Haplotype analysis
We used PHASE 2.1.1 [61] to phase associated and linked SNPs into haplotypes and GenABEL
to define associated SNPs, SNPs in LD (>0.8) and to plot haplotype distributions. In addition,
we used the Welsh two-sample t-test to detect significant differences between haplotypes in
dogs with different IgA levels using five percentile groups.
Fixation of associated SNPs
We calculated risk allele frequencies of the top SNPs in the IgA associated regions to evaluate
if associated SNPs in one breed were fixed (frequency>0.95) in any of the other breeds (S3
Table). In addition, we calculated the frequencies in a group of 350 dogs representing 25 breeds
(S15 Table) part of the dataset used in a previous study by Vaysse et. al., 2011 [62]). Breeds
with a suspected predisposition to low IgA levels were excluded from the initial dataset. Poorly
genotyped markers (call rate0.95) were excluded prior to the analysis.
Allele frequencies from eight dog breeds
To study detailed patterns of genetic variation in a ~3 Mb region spanning the SLIT1 locus
(CFA28: 9,000,091–11,999,424) we analyzed sequence data from 160 dogs from eight breeds
(20 dogs per breed, none of which were included in the GWAS) (S16 Table). Briefly, we used
Burrows-Wheeler Aligner, BWA [63] and GATK [64] following the best practice described by
GATK (https://www.broadinstitute.org/gatk/) to map sequence reads to the reference genome
and call variants. In total we characterized 13,004 variants (9486 SNPs and 3518 indels) in the
3 Mb region. Based on allele frequencies of the called variants, we then searched for regions of
fixation in the 20 GSDs and 20 LRs (S4 and S5 Tables, respectively). We calculated the propor-
tion of fixed variants in sliding windows of 11 variants (to obtain one centred variant and five
on each side) using one variant overlap and defined regions of fixation where the proportion
was set to 1 (i.e. all variants fixed within a window). We defined blocks of fixation by combin-
ing adjacent windows plus adding five variants (i.e. fixed variants based on the definition of
fixed regions) on each side, within a ~400 kb region (10,201,240–10,600,160), including SLIT1.
We also compared this region to human (hg19) to evaluate regulatory potential and transcrip-
tion factor binding sites. For comparison we also tried 25 variants per windows (one variant
overlap) resulting in a very similar pattern (S10 Fig). Thus, the results presented in this paper
(from 11 variant-windows) appear robust.
Fixation index for wolf versus dog
We utilized a previously published whole-genome resequencing data set [29], to investigate the
degree of genetic differentiation between dog and wolf in the CFA28 region that includes the
SLIT1 gene. To this end we first estimated allele frequencies throughout the autosomal part of
the genome in the dog and wolf population by counting allele specific sequencing reads in the
single wolf pool (12 wolves) and all five dog pools (60 dogs from 14 breeds) combined, respec-
tively. We then calculated Weir and Cockerhams (1984) version of the fixation index (FST) for
all SNPs. Given a minimum of 10 segregating sites per window we averaged FST values across
50 kb windows sliding 25 kb at a time and Z-transformed the resultant distribution. Next, we
used the same approach to calculate the average heterozygosity for the dog pools (HP) and
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Z-transformed the distribution. S8 and S9 Tables present the FST and HP, respectively, for the
studied region (CFA28: 10,053,171–10,978,044).
Pathway analyses
GRAIL. Regions of association within each breed were lifted over to the human genome
hg18 coordinates (genome.ucsc.edu/cgi-bin/hgLiftOver) with 50kb flanks on each side (S17
Table). Pathway analyses were performed with the web-based program GRAIL [30] using the
PubMed text (Aug 2012) database on the genomic regions with gene size correction turned on.
Connectivity between loci was tested in all breeds combined for IgA associated regions. The
key terms were presented in a ranking order based on both the uniqueness and specificity of
the term itself together with the number of genes in the regions involved in the particular path-
way. In addition, each gene was given a raw GRAIL p-value and the gene within each region
with the best connectivity (i.e. lowest raw GRAIL p-value) was also given a corrected GRAIL p-
value. Since only a subset of the genes had a corrected p-value, we considered a raw GRAIL
p< 0.05 significant.
INRICH. Gene set enrichment testing was performed with INRICH (INterval enRICH-
ment analysis), using 1,000,000 permutations to test the IgA associated regions for enrichments
in gene sets from the GO catalogue (downloaded from the INRICH website on 14 October
2014)[65]. We restricted the gene sets tested to between 5 and 1,000 genes in order to exclude
the widest GO terms. We used a reference map file of 17,099 genes lifted over to Canfam3.1
from the hg19 RefSeq Gene catalogue using the Liftover utility (downloaded from http://
hgdownload.cse.ucsc.edu/admin/exe/) with minMatch set to 0.45. We used the SNP map file
before QC (Canfam3.1: 172,950 markers).
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over. The proportion of variants with variation in 20 GSDs in sliding-windows (11 variants per
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genetic differentiation (FST) between dogs and wolves spanning a 75-kb region (windows with
FST> 0.67 are coloured in black) within the SLIT1 locus. FST values of two consecutive 50-kb
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respectively.
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S10 Fig. The proportion of variants with variation in GSD and LR within the SP associated
region on CFA28. By using a sliding window of 11 and 25 (for comparison) variants in LR
(A-B) and GSD (C-D), across 400 kb on CFA28, the proportion of variants with variation was
measured. Each bar representing one variant; 0 means no variation and 1 that all variants in
the window are polymorphic. Panel E shows the location of the top four SNPs in SP and the
genes in the UCSC browser.
(PDF)
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